Stephen John Kish

Stephen John Kish's AcademicInfluence.com Rankings

Stephen John Kish

Biology

#8229

World Rank

#11272

Historical Rank

Neuroscience

#1123

World Rank

#1165

Historical Rank

biology Degrees

Download Badge

Biology

Stephen John Kish's Degrees

PhD Neurobiology Stanford University

Why Is Stephen John Kish Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stephen John Kish's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. (1988) (1919)
Biochemical pathophysiology of Parkinson's disease. (1987) (908)
Striatal dopamine nerve terminal markers in human, chronic methamphetamine users (1996) (730)
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. (1997) (698)
Brain Cytochrome Oxidase in Alzheimer's Disease (1992) (542)
Kainic acid induced seizures: Neurochemical and histopathological changes (1983) (523)
In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining (1997) (453)
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. (2007) (330)
Glutathione peroxidase activity in Parkinson's disease brain (1985) (299)
Aging Produces a Specific Pattern of Striatal Dopamine Loss: Implications for the Etiology of Idiopathic Parkinson's Disease (1992) (275)
Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease (1996) (262)
Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. (2012) (230)
Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease (1996) (224)
Phenotypic Variability of Gerstmann-Straussler-Scheinker Disease is Associated with Prion Protein Heterogeneity (1998) (209)
The role of radiotracer imaging in Parkinson disease (2005) (205)
Hereditary form of parkinsonism—dementia (1998) (202)
Marked disparity between age‐related changes in dopamine and other presynaptic dopaminergic markers in human striatum (2003) (187)
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. (2013) (185)
In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO (2014) (182)
Dopa‐responsive dystonia: Pathological and biochemical observations in a case (1994) (179)
Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. (1997) (178)
Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? (2005) (178)
Pharmacologic mechanisms of crystal meth (2008) (172)
Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users (1996) (171)
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. (2010) (170)
Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. (2018) (167)
[11C]RTI‐32 PET studies of the dopamine transporter in early dopa‐naive Parkinson's disease (1997) (166)
Cerebral Cortex Gsα Protein Levels and Forskolin‐Stimulated Cyclic AMP Formation Are Increased in Bipolar Affective Disorder (1993) (163)
Hallervorden‐Spatz disease: Cysteine accumulation and cysteine dioxygenase deficiency in the globus pallidus (1985) (161)
Higher Binding of the Dopamine D3 Receptor-Preferring Ligand [11C]-(+)-Propyl-Hexahydro-Naphtho-Oxazin in Methamphetamine Polydrug Users: A Positron Emission Tomography Study (2012) (159)
Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease (1993) (157)
γ-AMINOBUTYRIC-ACID DEFICIENCY IN BRAIN OF SCHIZOPHRENIC PATIENTS (1979) (154)
Progressive supranuclear palsy: Relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers (1985) (154)
Why is parkinsonism not a feature of human methamphetamine users? (2004) (151)
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. (2010) (151)
Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. (1994) (149)
Influence of l-dopa and pramipexole on striatal dopamine transporter in early PD (2001) (148)
Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations (1998) (145)
Excitatory amino acids are elevated in human epileptic cerebral cortex (1988) (138)
Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder (1994) (135)
Brain neurotransmitters in dystonia musculorum deformans. (1986) (134)
The Vesicular Monoamine Transporter, in Contrast to the Dopamine Transporter, Is Not Altered by Chronic Cocaine Self-Administration in the Rat (1996) (134)
The Phosphoinositide Signal Transduction System Is Impaired in Bipolar Affective Disorder Brain (1996) (132)
Cognitive deficits in olivopontocerebellar atrophy: Implications for the cholinergic hypothesis of Alzheimer's dementia (1988) (130)
Postmortem cerebral cortex Gs α-subunit levels are elevated in bipolar affective disorder (1991) (127)
Current concepts in the diagnosis and management of Parkinson's disease. (2003) (123)
Mitochondria in Alzheimer's disease. (2002) (121)
How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? (2002) (119)
Incidence of Parkinson's disease among hospital patients with methamphetamine‐use disorders (2010) (118)
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia (1999) (118)
Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders (2017) (117)
Methamphetamine use and schizophrenia: a population-based cohort study in California. (2012) (117)
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia (1998) (116)
Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user (2000) (115)
Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients (1996) (115)
Brain polyamine levels are altered in Alzheimer's disease (1995) (114)
Brain protein and α‐ketoglutarate dehydrogenase complex activity in alzheimer‐s disease (1996) (114)
Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia (1999) (114)
Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder (2017) (113)
Elevated γ‐aminobutyric acid level in striatal but not extrastriatal brain regions in Parkinson's disease: Correlation with striatal dopamine loss (1986) (109)
Phospholipid‐Metabolizing Enzymes in Alzheimer's Disease: Increased Lysophospholipid Acyltransferase Activity and Decreased Phospholipase A2 Activity (1998) (108)
Reduced [3H]Cyclic AMP Binding in Postmortem Brain from Subjects with Bipolar Affective Disorder (1997) (105)
Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine (1994) (105)
Striatal Dopaminergic and Serotonergic Markers in Human Heroin Users (2001) (103)
Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease (1988) (102)
Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis (1996) (101)
Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO (2014) (99)
Brain serotonin transporter in human methamphetamine users (2009) (98)
γ‐VINYL GABA: EFFECTS OF CHRONIC ADMINISTRATION ON THE METABOLISM OF GABA AND OTHER AMINO COMPOUNDS IN RAT BRAIN (1979) (98)
Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations (2001) (97)
Increased Vesicular Monoamine Transporter Binding during Early Abstinence In Human Methamphetamine Users: Is VMAT2 a Stable Dopamine Neuron Biomarker? (2008) (96)
Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? (2003) (95)
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. (2009) (92)
Elevated serotonin and reduced dopamine in subregionally divided Huntington's disease striatum (1987) (91)
Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype (2004) (90)
Delineation of Somatic Nerve Endings in Rat Teeth by Radioautography of Axon-Transported Protein (1976) (88)
GTP‐cyclohydrolase I gene mutations in hereditary progressive and dopa‐responsive dystonia (1996) (88)
Levels of 4-Hydroxynonenal and Malondialdehyde Are Increased in Brain of Human Chronic Users of Methamphetamine (2006) (88)
Brain proteasomal function in sporadic Parkinson's disease and related disorders (2002) (87)
Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation (2015) (85)
Blood, brain, and hair GHB concentrations following fatal ingestion. (2001) (85)
Learning is improved by a soybean oil diet in rats. (1986) (83)
Somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions in the central nervous system (1997) (82)
Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation (2000) (80)
Brain antioxidant systems in human methamphetamine users (2004) (77)
Ornithine Decarboxylase in Human Brain: Influence of Aging, Regional Distribution, and Alzheimer's Disease (1998) (77)
Dopa‐responsive dystonia: Recent advances and remaining issues to be addressed (1999) (76)
Striatal 3,4‐dihydroxyphenylalanine decarboxylase in aging: Disparity between postmortem and positron emission tomography studies? (1995) (75)
Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users. (2001) (74)
Noradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects (1994) (74)
REGIONAL DISTRIBUTION OF HOMOCARNOSINE, HOMOCARNOSINE‐CARNOSINE SYNTHETASE AND HOMOCARNOSINASE IN HUMAN BRAIN (1979) (73)
Increased Cyclic AMP‐Dependent Protein Kinase Activity in Postmortem Brain from Patients with Bipolar Affective Disorder (1999) (72)
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients (2012) (72)
Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease (2003) (70)
Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and machado‐joseph disease (1996) (69)
Neurotransmitter amino acids in dominantly inherited cerebellar disorders (1981) (69)
Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users (2008) (69)
Brain thiamine, its phosphate esters, and its metabolizing enzymes in alzheimer's disease (1996) (69)
Brain Energy Metabolizing Enzymes in Alzheimer's Disease: α‐Ketoglutarate Dehydrogenase Complex and Cytochrome Oxidase a (1997) (69)
Phospholipid biosynthetic enzymes in human brain (1997) (68)
Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users (2000) (68)
[3H]Vesamicol binding in human brain cholinergic deficiency disorders (1990) (67)
Decreased Brain Protein Levels of Cytochrome Oxidase Subunits in Alzheimer's Disease and in Hereditary Spinocerebella Ataxia Disorders (1999) (66)
Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. (1999) (65)
Brain neurotransmitter changes in human narcolepsy (1992) (64)
Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. (2011) (63)
Polyamines in Human Brain: Regional Distribution and Influence of Aging (1995) (63)
Mapping Human Brain Fatty Acid Amide Hydrolase Activity with PET (2013) (62)
Brain glutathione peroxidase in neurodegenerative disorders. (1986) (62)
Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users (2016) (61)
Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study. (2019) (60)
Thalamic noradrenaline in Parkinson's disease: Deficits suggest role in motor and non‐motor symptoms (2012) (60)
Thiamine, Thiamine Phosphates, and Their Metabolizing Enzymes in Human Brain (1996) (60)
Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine (1998) (58)
Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. (1998) (58)
Increased Gαq/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder (1997) (57)
Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. (1990) (56)
Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography. (2014) (55)
Dopa‐responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene (2000) (54)
Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia (1994) (54)
The Fatty Acid Amide Hydrolase C385A Variant Affects Brain Binding of the Positron Emission Tomography Tracer [11C]CURB (2015) (54)
Neurochemical Basis of Dementia in Parkinson’s Disease (1984) (53)
Neurokinetics of lidocaine in the infraorbital nerve of the rat in vivo: Relation to sensory block. (1975) (53)
Cerebellar norepinephrine in patients with Parkinson's disease and control subjects. (1984) (52)
Down's Syndrome Individuals Begin Life with Normal Levels of Brain Cholinergic Markers (1989) (52)
Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain. (1991) (52)
Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. (1993) (52)
Regional distribution of cocaine in postmortem brain of chronic human cocaine users. (2000) (50)
Elevated Monoamine Oxidase A Binding During Major Depressive Episodes Is Associated with Greater Severity and Reversed Neurovegetative Symptoms (2014) (49)
Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. (2006) (49)
Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy (1995) (48)
Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease (2001) (47)
Characterization of Lysophospholipid Metabolizing Enzymes in Human Brain (1994) (47)
All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study. (2012) (46)
Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. (2003) (46)
Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). (2004) (44)
Characterization of a Novel Phospholipase A2 Activity in Human Brain (1995) (44)
Autoradiographic analysis of benzodiazepine binding in entorhinal-kindled rat brains (1989) (43)
Brain dopamine neurone ‘damage’: methamphetamine users vs. Parkinson's disease – a critical assessment of the evidence (2017) (43)
Non‐Alzheimer‐type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy (1989) (42)
Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease (1998) (42)
D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia (2016) (42)
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB (2016) (41)
Elevation of Brain GABA Content by Chronic Low‐Dosage Administration of Hydrazine, a Metabolite of Isoniazid (1981) (41)
Reversible Inhibition of Rapid Axonal Transport in Vivo by Lidocaine Hydrochloride (1976) (39)
Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy (1992) (39)
Regional brain [3H]muscimol binding in kindled rat brain: a quantitative autoradiographic examination (1990) (39)
HOMOCARNOSINOSIS: INCREASED CONTENT OF HOMOCARNOSINE AND DEFICIENCY OF HOMOCARNOSINASE IN BRAIN (1979) (39)
Dementia, parkinsonism, and motor neuron disease: Neurochemical and neuropathological correlates (1988) (38)
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig. (1985) (38)
Immunoreactive Levels of α-ketoglutarate Dehydrogenase Subunits in Friedreich's Ataxia and Spinocerebellar Ataxia Type 1 (1996) (37)
Neurochemical Abnormalities in Brains of Renal Failure Patients Treated by Repeated Hemodialysis (1985) (37)
Rapid axonal transport in trigeminal nerve of rat (1975) (36)
Do glutathione levels decline in aging human brain? (2016) (36)
Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy. (1988) (36)
Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. (2002) (36)
Brain biopterin and tyrosine hydroxylase in asymptomatic dopa‐responsive dystonia (2002) (35)
Mosaicism of the CAG repeat in CNS tissue in relation to age at death in spinocerebellar ataxia type 1 and Machado-Joseph disease patients. (1997) (35)
Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking human epileptic cortex. (1988) (35)
What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease? (2003) (35)
Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. (2006) (34)
Opioid peptides in Huntington's disease: Alterations in prodynorphin and proenkephalin system (1986) (33)
Is brain gliosis a characteristic of chronic methamphetamine use in the human? (2014) (33)
Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans). (1988) (32)
Increased activity of choline acetyltransferase and acetylcholinesterase in actively epileptic human cerebral cortex (1988) (32)
Brain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy (2004) (31)
Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity. (2019) (31)
Selective delayed alternation deficits in dominantly inherited olivopontocerebellar atrophy (1991) (31)
Effects of chronic administration of antipsychotic drugs on GABA and other amino acids in the mesolimbic area of rat brain. (1979) (30)
Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. (1996) (30)
Neurochemical abnorrnalities in a patient with ataxia‐ telangiectasia (1984) (30)
Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder (2020) (29)
Identification of a noradrenaline‐rich subdivision of the human nucleus accumbens (2006) (29)
Dopa‐responsive dystonia due to mild tyrosine hydroxylase deficiency (2004) (29)
Blocking of Fatty Acid Amide Hydrolase Activity with PF-04457845 in Human Brain: A Positron Emission Tomography Study with the Novel Radioligand [11C]CURB (2015) (28)
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors (2015) (28)
Postmortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder. (1991) (28)
Cerebellar [3H]inositol 1,4,5-trisphosphate binding is markedly decreased in human olivopontocerebellar atrophy (1989) (28)
Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy (1987) (28)
The polyamine synthesis inhibitor alpha-difluoromethylornithine is neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo. (1991) (27)
Greater Monoamine Oxidase A Binding in Alcohol Dependence (2014) (26)
Brain levels of neuropeptides in human chronic methamphetamine users (2007) (26)
Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications (2017) (25)
Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study (2011) (25)
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls (2017) (25)
Brain vesicular acetylcholine transporter in human users of drugs of abuse (2004) (25)
Distribution of Vesicular Monoamine Transporter 2 Protein in Human Brain: Implications for Brain Imaging Studies (2011) (25)
Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease (1993) (24)
Alterations in benzodiazepine and GABA receptor binding in rat brain following systemic injection of kainic acid (1983) (23)
Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity (1999) (23)
Increased G alpha q/11 immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder. (1997) (22)
Benzodiazepine Receptor Binding in Cerebellar Cortex: Observations in Olivopontocerebellar Atrophy (1984) (22)
Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene (2000) (22)
Binding of [3H]flunitrazepam and [3H]Ro5-4864 to crude homogenates of amygdala-kindled rat brain: two months post-seizure (1983) (21)
Replicating predictive serum correlates of greater translocator protein distribution volume in brain (2019) (21)
Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine (1994) (21)
Phospholipase A2 Activity Is Selectively Decreased in the Striatum of Chronic Cocaine Users (1996) (21)
GERSTMANN-STRÄUSSLER-SCHEINKER DISEASE (GSS) WITH A MUTATION AT PRION PROTEIN (PrP) RESIDUE 212 (1998) (20)
Increased GABA receptor binding in dominantly-inherited cerebellar ataxias (1983) (20)
Narcolepsy Secondary to Fourth Ventricular Subependymoma (1996) (20)
Amantadine for levodopa‐induced choreic dyskinesia in compound heterozygotes for GCH1 mutations (2004) (19)
Decreased binding of the D-3 dopamine receptor-preferring ligand [C-11]-()-PHNO in drug-nave Parkinsons disease (2009) (19)
Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain (2011) (18)
Decreased benzodiazepine receptor binding in amygdala-kindled rat brains. (1983) (18)
Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence (2016) (18)
Quantity and frequency of cannabis use in relation to cannabis-use disorder and cannabis-related problems. (2020) (18)
Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB (2020) (18)
Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: a case report. (2014) (17)
Brain benzodiazepine receptor binding and purine concentration in Lesch-Nyhan syndrome (1985) (17)
TRPC3 protein is expressed across the lifespan in human prefrontal cortex and cerebellum (2009) (16)
Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy (1993) (16)
Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type‐1 (2000) (16)
Cerebellar α‐Ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1 (1994) (16)
Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia. (1998) (15)
Reduced Striatal [3H]Inositol 1,4,5‐Trisphosphate Binding in Huntington's Disease (1991) (15)
S-adenosylmethionine decarboxylase in human brain. Regional distribution and influence of aging. (1993) (15)
Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1 (1997) (15)
Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type‐1 (1998) (15)
Brain γ‐aminobutyric acid deficiency in dialysis encephalopathy (1985) (15)
Whole-Body Radiation Dosimetry of 11C-Carbonyl-URB694: A PET Tracer for Fatty Acid Amide Hydrolase (2014) (14)
Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users : Imaging With the Novel Radiotracer [ 11 C ] CURB (2016) (14)
Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy (1991) (14)
Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens (2007) (14)
Identification of extrasynaptic binding sites for [3H]GABA in peripheral nerve (1985) (14)
[3H]Inositol 1,4,5-trisphosphate binding in human cerebral cortex (1988) (13)
Cerebral cortex β-adrenoceptor binding in bipolar affective disorder (1994) (13)
GABA-dopamine relationship in Parkinson's disease striatum. (1987) (13)
Influence of development and aging on brain biopterin (1998) (13)
Brain amino acid reductions in one family with chromosome 6p—linked dominantly inherited olivopontocerebellar atrophy (1991) (12)
D3 dopamine receptors and a missense mutation of fatty acid amide hydrolase linked in mouse and men: implication for addiction (2019) (12)
Does Hyperthyroidism Increase Risk of Death Due to the Ingestion of Ecstasy? (2007) (12)
Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1. (1996) (12)
Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1 (1996) (12)
Personality disorder symptomatology is associated with anomalies in striatal and prefrontal morphology (2015) (12)
Canada's cannabis legalization and drivers' traffic-injury presentations to emergency departments in Ontario and Alberta, 2015-2019. (2021) (12)
Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation (2003) (12)
Corticotropin-releasing hormone and dopamine release in healthy individuals (2017) (12)
Brain neurotransmitters in glycine encephalopathy (1988) (12)
Glycerophosphoethanolamine concentration is elevated in brain of patients with dominantly inherited olivopontocerebellar atrophy (1990) (11)
Reduction of Noradrenaline in Cerebellum of Patients with Olivopontocerebellar Atrophy (1984) (11)
Impacts of Canada's cannabis legalization on police-reported crime among youth: early evidence. (2021) (11)
Autoradiographic analysis of [35S]TBPS binding in entorhinal cortex-kindled rat brains (1992) (11)
Concentration, distribution, and influence of aging on the 18 kDa translocator protein in human brain: Implications for brain imaging studies (2020) (11)
Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain (2001) (10)
Regional distribution of guanine nucleotide binding proteins (Gs and Gi α) in human brain: correlation with adenylyl cyclase activity (1993) (10)
Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications (2017) (10)
The Pathology of Methamphetamine Use in the Human Brain (2014) (10)
Inhibition of fatty acid amide hydrolase by BIA 10-2474 in rat brain (2017) (10)
Fatty acid amide hydrolase binding is inversely correlated with amygdalar functional connectivity: a combined positron emission tomography and magnetic resonance imaging study in healthy individuals (2021) (10)
Elevated Stimulatory and Reduced Inhibitory G Protein α Subunits in Cerebellar Cortex of Patients with Dominantly Inherited Olivopontocerebellar Atrophy (1993) (9)
Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F‐18]FEPPA (2020) (9)
Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study. (2017) (9)
Association of the Fatty Acid Amide Hydrolase C385A Polymorphism with Alcohol Use Severity and Coping Motives in Heavy-drinking Youth. (2021) (9)
Normal serotonin but elevated 5-hydroxyindoleacetic acid concentration in cerebellar cortex of patients with dominantly-inherited olivopontocerebellar atrophy (1992) (9)
Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. (2018) (8)
Activity of S-adenosylmethionine decarboxylase, a key regulatory enzyme in polyamine biosynthesis, is increased in epileptogenic human cortex. (1994) (8)
Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia. (2015) (8)
Neurochemical Aspects of Parkinson’s Disease and the Dementing Brain Disorders: Relation to Brain Ageing (1990) (8)
Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls (2015) (7)
Neuronal [3H]Benzodiazepine Binding and Levels of GABA, Glutamate, and Taurine Are Normal in Huntington's Disease Cerebellum (1983) (7)
Desipramine reduces plasma but not brain thyroxine levels (1993) (7)
Multiple forms of the enzyme glycerophosphodiesterase are present in human brain (1995) (7)
Subchronic glucocorticoids, glutathione depletion and a postpartum model elevate monoamine oxidase a activity in the prefrontal cortex of rats (2017) (7)
Influence of Chronic Cocaine on Monoamine Neurotransmitters in Human Brain and Animal Model: Preliminary Observations (1992) (7)
Elevated monoamine oxidase A activity and protein levels in rodent brain during acute withdrawal after chronic intermittent ethanol vapor exposure. (2018) (6)
A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia (2016) (6)
A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder (2021) (6)
Tyrosine Hydroxylase Deficiency (2014) (6)
Cerebellar alpha-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1. (1994) (6)
PRION PROTEIN ISOFORMS IN THE NEW VARIANT OF GERSTMAN-STRÄUSSLER-SCHEINKER DISEASE Q212P (1998) (6)
Regional thyroid hormone levels in rat brain (1994) (5)
Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019 (2022) (5)
Serotonin transporter protein in autopsied brain of chronic users of cocaine (2020) (5)
Cerebellar glutamate metabolizing enzymes in spinocerebellar ataxia type I (1994) (4)
Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy. (1993) (3)
Brain aconitase activity is not decreased in progressive supranuclear palsy (2002) (3)
Increased vesicular monoamine transporter binding during early abstinence from chronic methamphetamine abuse: Preliminary PET/(+)[11C]DTBZ findings (2008) (3)
Dopaminergic changes in human brain following acute exposure to γ-hydroxybutyrate (2001) (3)
Cerebral cortex beta-adrenoceptor binding in bipolar affective disorder. (1994) (3)
Altered CTX‐catalyzed and endogenous [32P]ADP‐ribosylation of stimulatory G protein αs isoforms in postmortem bipolar affective disorder temporal cortex (2003) (2)
Inability to produce a model of dialysis encephalopathy in the rat by aluminum administration (1987) (2)
THE NIGROSTRIATAL DOPAMINE SYSTEM IN PATIENTS WITH DOMINANTLY-INHERITED OLIVOPONTOCEREBELLAR ATROPHY: NEUROPATHOLOGICAL-BIOCHEMICAL CORRELATES (1990) (2)
Rats chronically injected with urine from Huntington's chorea patients do not incur striatal damage (1981) (2)
Brain γ-aminobutyric acid and benzodiazepine receptor binding in dialysis encephalopathy (1985) (2)
Is a circulating neurotoxin involved in the pathogenesis of Huntington's chorea? (1985) (2)
Professor Oleh Hornykiewicz, MD (1926–2020): Remembering the Father of the Modern Treatment of Parkinson's Disease and the Man (2020) (2)
Effects of MDMA (ecstasy) use and abstention on serotonin neurons (2002) (1)
T76. Involvement of the Endocannabinoid Enzyme Fatty Acid Amide Hydrolase in the Neurobiology of Impulsivity: Positron Emission Tomography Studies With [11C]CURB (2018) (1)
619. Brain Levels of Fatty Acid Amide Hydrolase Are Not Altered in Overweight Healthy Individuals: A Pilot PET Study with [11C]CURB (2017) (1)
49. Reduced nucleus accumbens Gαi immunolabeling in chronic drug users (1998) (1)
FATAL HYPERTHERMIA SYNDROME. REPLY (1991) (1)
Brain gamma-aminobutyric acid deficiency in dialysis encephalopathy. (1985) (1)
BRAIN NORADRENERGIC CHANGES IN A PATIENT WITH WILSONʼS DISEASE: 58 (1990) (1)
INVOLVEMENT OF THE PEDUNCULO PONTINE TEGMENTAL NUCLEUS IN FAMILIAL OLIVOPONTOCEREBELLAR ATROPHY: 240 (1989) (1)
Exploring brain morphology in poly-stimulant abuse: shape, volume, and surface area abnormalities in Ecstasy-cocaine- and methamphetamine-preferring individuals (2015) (1)
Table 1. [Summary of Molecular Genetic Testing Used in Tyrosine Hydroxylase Deficiency]. (2014) (0)
Limiting production of crystal meth (2008) (0)
dominantly-inherited olivopontocerebellar atrophy (0)
[C-11]PHNO and [C-11]racloride PET imaging of dopamine receptors in drug-naive Parkinson's disease (2008) (0)
Characteristic neurochemical changes in the substantia nigra (SN) and striatum of symptomatic versus asymptomatic dopa-responsive dystonia (DRD) (2017) (0)
Fatty Acid Amide Hydrolase and Threat Related Amygdala Activity: A Combined Positron Emission Tomography and Magnetic Resonance Imaging Study (2020) (0)
Highly Reproducible in vivo T 1 Maps in brain at 3 T (2012) (0)
P.6.a.002 Monoamine oxidase A binding during acute alcohol withdrawal: a [C]-harmine PET study (2012) (0)
[Table, GeneReview Scope]. (2014) (0)
Brain gamma-aminobutyric acid and benzodiazepine receptor binding in dialysis encephalopathy. (1985) (0)
BRAIN CHOLINEACETYLTRANSFERASE AND ACETYLCHOLINESTERASE ARE NOT REDUCED IN INFANT DOWN'S SYNDROME BRAIN (1988) (0)
44 – INHIBITION AND RECOVERY OF RAPID AXONAL TRANSPORT IN VIVO FOLLOWING LIDOCAINE BLOCK OF PERIPHERAL NERVE (1977) (0)
Endocannabinoid Metabolism in Posttraumatic Stress Disorder: Results From a Neuroimaging Study With the Novel Fatty Acid Amide Hydrolase Probe, [C-11] Curb (2020) (0)
BRAIN CHOLINERGIC CHANGES IN HEREDITARY OLIVOPONTOCEREBELLAR ATROPHY.: 23 (1987) (0)
Decreased striatal [3H]-IP3 binding in Huntington's disease (1989) (0)
A question of ethics (2008) (0)
Table 3. [Selected TH Allelic Variants]. (2014) (0)
Alterations in brain dipeptide and amino acid content in neurological and psychiatric disorders (1980) (0)
LETTER TO THE EDITOR Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia (2015) (0)
Rats chronically injected with urine from Huntington's chorea patients do not striatal damage. (1981) (0)
Response to Manthey, Carr, and Rehm. (2019) (0)
Dr. Kish and Associates Reply (1991) (0)
ABSENCE OF IMMUNOCYTOCHEMICALLY DETECTABLE ß A4 IN DOMINANTLY INHERITED OPCA (1993) (0)
Narcolepsy Secondary to Fourth Ventricular (0)
GreaterMonoamine Oxidase A Binding in Perimenopausal Age asMeasuredWith Carbon 11 – Labeled Harmine Positron Emission Tomography (2014) (0)
Does sodium oxybate inhibit brain dopamine release in humans? An exploratory neuroimaging study (2021) (0)
Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019. (2023) (0)
Parkinson's disease, impulse control disorder and the D3 dopamine receptor system: Preliminary PET imaging studies with [11C](+)PHNO comparison with [11C]racloride (2010) (0)
Table 1. [Molecular Genetic Testing Used in Tyrosine Hydroxylase Deficiency]. (2017) (0)
Brain Dopamine and Other Neurotransmitters in Neuronal Intranuclear Inclusion Body Disorder (1986) (0)
Comparative hazards of acute myocardial infarction among hospitalized patients with methamphetamine- or cocaine-use disorders: A retrospective cohort study (2017) (0)
Investigating Brain Monoamine Oxidase B Status in Alcohol Use Disorder With the Positron Emission Tomography (PET) Tracer [C-11]SL25.1188 (2020) (0)
Canada’s cannabis legalization and police-reported cannabis-related criminal incidents among youth, 2015-2021. (2023) (0)
Table 2. [Characteristics of the Three Phenotypes of TH Deficiency]. (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stephen John Kish?

Stephen John Kish is affiliated with the following schools:

University of Toronto
University of Washington